Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Wendling

Showing results (161-170 of 496) with videos related to

Pageof 50
Sort By:
The Journal of Rheumatology|September 16, 2021
Abatacept as Adjunctive Therapy in Refractory Polymyalgia RheumaticaEric Toussirot, Martin Michaud, Daniel Wendling, et al.
Clinical Rheumatology|September 19, 2025
Patterns and prevalence of sacroiliac joint bone marrow edema during pregnancy: A retrospective analysisFrank Verhoeven, Pierre Verdot, Daniel Wendling, et al.
Clinical Rheumatology|May 23, 2026
Discrepancies in the assessment of axial spondyloarthritis between patients and rheumatologists: what does this mean?Daniel Wendling, Olivier Fakih, Frank Verhoeven, et al.
Joint Bone Spine|July 12, 2015
Spondyloarthritis: A concept or a disease?Daniel Wendling, Pascal Claudepierre, Clément Prati, et al.
Rheumatology (Oxford, England)|October 20, 2019
Paradoxical Löfgren's syndrome in a patient treated with rituximab: interferon is not the keyOlivier Fakih, Frank Verhoeven, Clément Prati, et al.
Joint Bone Spine|October 14, 2021
Differences in distribution by department of prevalence and incidence of spondyloarthritis and inflammatory bowel diseases declared to the French National Health Insurance and their evolution between 2008 and 2018Olivier Fakih, Clément Prati, Daniel Wendling, et al.
Joint Bone Spine|February 13, 2009
A plea for reason in using magnetic resonance imaging for the diagnostic and therapeutic management of spondyloarthropathiesPhilippe Goupille, Thao Pham, Pascal Claudepierre, et al.
Expert Opinion on Biological Therapy|July 7, 2017
Etanercept for treating axial spondyloarthritisXavier Guillot, Clément Prati, Maxime Sondag, et al.
Joint Bone Spine|July 4, 2018
Costovertebral arthritis revealing spondyloarthritisDaniel Wendling, Sébastien Aubry, Frank Verhoeven, et al.
Joint Bone Spine|April 5, 2011
Optimizing TNFα antagonist therapy in patients with spondyloarthritis: why and how?Daniel Wendling, Clément Prati, Philippe Goupille, et al.
Pageof 50

Showing results (161-170 of 496) with videos related to

Sort By:
Pageof 50
The Journal of Rheumatology|September 16, 2021
Abatacept as Adjunctive Therapy in Refractory Polymyalgia RheumaticaEric Toussirot, Martin Michaud, Daniel Wendling, et al.
Clinical Rheumatology|September 19, 2025
Patterns and prevalence of sacroiliac joint bone marrow edema during pregnancy: A retrospective analysisFrank Verhoeven, Pierre Verdot, Daniel Wendling, et al.
Clinical Rheumatology|May 23, 2026
Discrepancies in the assessment of axial spondyloarthritis between patients and rheumatologists: what does this mean?Daniel Wendling, Olivier Fakih, Frank Verhoeven, et al.
Joint Bone Spine|July 12, 2015
Spondyloarthritis: A concept or a disease?Daniel Wendling, Pascal Claudepierre, Clément Prati, et al.
Rheumatology (Oxford, England)|October 20, 2019
Paradoxical Löfgren's syndrome in a patient treated with rituximab: interferon is not the keyOlivier Fakih, Frank Verhoeven, Clément Prati, et al.
Joint Bone Spine|October 14, 2021
Differences in distribution by department of prevalence and incidence of spondyloarthritis and inflammatory bowel diseases declared to the French National Health Insurance and their evolution between 2008 and 2018Olivier Fakih, Clément Prati, Daniel Wendling, et al.
Joint Bone Spine|February 13, 2009
A plea for reason in using magnetic resonance imaging for the diagnostic and therapeutic management of spondyloarthropathiesPhilippe Goupille, Thao Pham, Pascal Claudepierre, et al.
Expert Opinion on Biological Therapy|July 7, 2017
Etanercept for treating axial spondyloarthritisXavier Guillot, Clément Prati, Maxime Sondag, et al.
Joint Bone Spine|July 4, 2018
Costovertebral arthritis revealing spondyloarthritisDaniel Wendling, Sébastien Aubry, Frank Verhoeven, et al.
Joint Bone Spine|April 5, 2011
Optimizing TNFα antagonist therapy in patients with spondyloarthritis: why and how?Daniel Wendling, Clément Prati, Philippe Goupille, et al.
Pageof 50